The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_130839.5(UBE3A):c.*4A>G

CA7435334

597013 (ClinVar)

Gene: UBE3A
Condition: Angelman syndrome
Inheritance Mode: Autosomal dominant inheritance
UUID: a9a9f0ea-47c2-42a9-9217-5c48eff9cf92
Approved on: 2023-06-15
Published on: 2023-06-21

HGVS expressions

NM_130839.5:c.*4A>G
NM_130839.5(UBE3A):c.*4A>G
NC_000015.10:g.25339133T>C
CM000677.2:g.25339133T>C
NC_000015.9:g.25584280T>C
CM000677.1:g.25584280T>C
NC_000015.8:g.23135373T>C
NG_009268.1:g.104849A>G
ENST00000438097.6:c.*4A>G
ENST00000635914.1:c.*948A>G
ENST00000636667.1:c.*4A>G
ENST00000637886.1:c.*4A>G
ENST00000638011.1:c.*4A>G
ENST00000638155.1:c.*4A>G
ENST00000648336.2:c.*4A>G
ENST00000649550.1:c.*4A>G
ENST00000650110.1:c.*4A>G
ENST00000232165.7:c.*4A>G
ENST00000428984.6:c.*4A>G
ENST00000566215.5:c.*4A>G
ENST00000614096.4:c.*4A>G
ENST00000626176.2:n.434A>G
ENST00000630424.2:c.*4A>G
NM_000462.3:c.*4A>G
NM_130838.1:c.*4A>G
NM_130839.2:c.*4A>G
NM_000462.5:c.*4A>G
NM_001354505.1:c.*4A>G
NM_001354506.1:c.*4A>G
NM_001354507.1:c.*4A>G
NM_001354508.1:c.*4A>G
NM_001354509.1:c.*4A>G
NM_001354511.1:c.*4A>G
NM_001354512.1:c.*4A>G
NM_001354513.1:c.*4A>G
NM_001354523.1:c.*4A>G
NM_001354526.1:c.*4A>G
NM_001354538.1:c.*4A>G
NM_001354539.1:c.*4A>G
NM_001354540.1:c.*4A>G
NM_001354541.1:c.*4A>G
NM_001354542.1:c.*4A>G
NM_001354543.1:c.*4A>G
NM_001354544.1:c.*4A>G
NM_001354545.1:c.*4A>G
NM_001354546.1:c.*4A>G
NM_001354547.1:c.*4A>G
NM_001354548.1:c.*4A>G
NM_001354549.1:c.*4A>G
NM_001354550.1:c.*4A>G
NM_001354551.1:c.*4A>G
NM_130838.3:c.*4A>G
NM_130839.4:c.*4A>G
NR_146177.1:n.18393-52463T>C
NR_148916.1:n.3167A>G
NM_001354506.2:c.*4A>G
NM_001354507.2:c.*4A>G
NM_001354508.2:c.*4A>G
NM_001354509.2:c.*4A>G
NM_001354511.2:c.*4A>G
NM_001354512.2:c.*4A>G
NM_001354513.2:c.*4A>G
NM_001354523.2:c.*4A>G
NM_001354538.2:c.*4A>G
NM_001354539.2:c.*4A>G
NM_001354540.2:c.*4A>G
NM_001354541.2:c.*4A>G
NM_001354542.2:c.*4A>G
NM_001354543.2:c.*4A>G
NM_001354544.2:c.*4A>G
NM_001354545.2:c.*4A>G
NM_001354546.2:c.*4A>G
NM_001354547.2:c.*4A>G
NM_001354548.2:c.*4A>G
NM_001354549.2:c.*4A>G
NM_001354550.2:c.*4A>G
NM_001354551.2:c.*4A>G
NM_001374461.1:c.*4A>G
NM_130838.4:c.*4A>G
NR_148916.2:n.3135A>G

Uncertain Significance

Not Met criteria codes 1
BS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The c.*4A>G variant in UBE3A (NM_130838.2) is present in gnomAD v2.1.1 at a frequency of 0.0068% in the European (non-Finnish) sub population (no criteria met). In summary, the c.*4A>G variant in UBE3A is classified as Variant of Uncertain Significance based on the ACMG/AMP criteria (no criteria met).
Not Met criteria codes
BS1
The c.*4A>G variant in UBE3A (NM_130838.2) is present in gnomAD v2.1.1 at a frequency of 0.0068% in the European (non-Finnish) sub population (no criteria met).
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.